Infant post-exposure prophylaxis Which drugs should be used for infant PEP and for how long? Should PCP prophylaxis be administered to the neonate? Infant feeding Is an update required to the BHIVA position statement? If mother breastfeeds, how frequently should mother and baby be monitored and what tests should be used? How should infants be fed (breast

or bottle)? Infant testing What tests should be undertaken on the neonate and when? Study design: SRs, RCTs, observational, Roxadustat risk, economic Population: HIV-positive women Intervention: starting ART during pregnancy Comparator: none Outcomes: death, AIDS, non AIDS co-morbidities, maternal obstetric morbidity, GDC-0068 cost infant mortality and morbidity, mother-to-child HIV transmission,

drug resistance. HIV monitoring What baseline tests should be recommended for HIV-positive women? How often should they be repeated? How should we investigate and manage abnormal liver function in pregnancy? Sexual health When should we recommend sexual health screening and how often? How should we manage genital infections in HIV-positive pregnant women? Component Description Review area Safety and efficacy of antiretrovirals in pregnancy

Objectives To assess the benefits and risks of ART in pregnancy Populations HIV-positive women who are pregnant, Oxymatrine HIV-positive women of child-bearing age Interventions ART (all drugs) Comparisons/aspects covered by search Between antiviral regimens and historical data where appropriate Outcomes To be decided by Writing Groups Study designs SRs, RCTs, observational studies, risk, economic Exclusions Animal studies, letters, editorials, comments, case reports, non-English studies How the information was searched Databases: Medline, Embase, Cochrane Library, Conference abstracts 2008–2011 Language: restrict to English only Date parameters: –July 2011 Published abstracts: 239 Conference abstracts: 105 Townsend CL, Cortina-Borja M, Peckham CS, de Ruiter A, Lyall H, Tookey PA. Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000–2006. AIDS 2008; 22: 973–981.